A nationwide utilization survey of therapeutic drug monitoring for five antibiotics in South Korea

References

• van Altena R, Dijkstra JA, van der Meer ME, et al. Reduced chance of hearing loss associated with therapeutic drug monitoring of aminoglycosides in the treatment of multidrug-resistant tuberculosis. Antimicrob Agents Chemother. 2017;61(3). doi:10.1128/AAC.01400-16
   Web of Science ®Google Scholar
• World Health Organization. 2016–2017. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2017 Available from: https://apps.who.int/iris/bitstream/handle/10665/259744/9789241513449-eng.pdf;jsessionid=0BD793C9FADB1F9B559EA9E8C6102E63?sequence=1. 314, 2019.
   Google Scholar
• Reeves D, Lovering A, Thomson A. Therapeutic drug monitoring in the past 40 years of the journal of antimicrobial chemotherapy. J Antimicrob Chemother. 2016;71(12):3330–3332. doi:10.1093/jac/dkw40827856702
   PubMed Web of Science ®Google Scholar
• Bates DW, Soldin SJ, Rainey PM, Micelli JN. Strategies for physician education in therapeutic drug monitoring. Clin Chem. 1998;44(2):401–407.9474051
   PubMed Web of Science ®Google Scholar
• Ye ZK, Tang HL, Zhai SD. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. PLoS One. 2013;8(10):e77169. doi:10.1371/journal.pone.007716924204764
   PubMed Web of Science ®Google Scholar
• Schroeder LF, Guarner J, Amukele TK. Essential diagnostics for the use of world health organization essential medicines. Clin Chem. 2018;64(8):1148–1157. doi:10.1373/clinchem.2017.27533929871869
   PubMed Web of Science ®Google Scholar
• Filippone EJ, Kraft WK, Farber JL. The nephrotoxicity of vancomycin. Clin Pharmacol Ther. 2017;102(3):459–469. doi:10.1002/cpt.72628474732
   PubMed Web of Science ®Google Scholar
• Murray BE, Arias CA, Nannini EC. Glycopeptides (Vancomycin and Teicoplanin), Streptogramins (Quinupristin-Dalfopristin), Lipopeptides (Daptomycin), and Lipoglycopeptides (Telavancin). In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases (Eighth Edition). Elsevier Health Sciences, Philadelphia; 2015: 377–400.e374.
   Google Scholar
• Craig WA. Optimizing aminoglycoside use. Crit Care Clin. 2011;27(1):107–121. doi:10.1016/j.ccc.2010.11.00621144989
   PubMed Web of Science ®Google Scholar
• Banerjee S, Narayanan M, Gould K. Monitoring aminoglycoside level. BMJ. 2012;345:e6354.23044986
   PubMed Web of Science ®Google Scholar
• Huth ME, Han KH, Sotoudeh K, et al. Designer aminoglycosides prevent cochlear hair cell loss and hearing loss. J Clin Invest. 2015;125(2):583–592. doi:10.1172/JCI7742425555219
   PubMed Web of Science ®Google Scholar
• Chae H, Lee JJ, Cha K, et al. Measurement of teicoplanin concentration with liquid chromatography-tandem mass spectrometry method demonstrates the usefulness of therapeutic drug monitoring in hematologic patient populations. Ther Drug Monit. 2018;40(3):330–336. doi:10.1097/FTD.000000000000049829746433
   PubMed Web of Science ®Google Scholar
• Ko DH, Gu GG, Cho EJ, Shin ES, Chun S, Kim JH. As therapeutic drug monitoring subcommittee, Korean association of external quality assessment service. Annual report on the external quality assessment of therapeutic drug monitoring and testing for drugs of abuse in Korea (2015). J Lab Med Qual Assur. 2016;38(1):11–21. doi:10.15263/jlmqa.2016.38.1.11
   Google Scholar
• Ab Rahman AF, Ahmed Abdelrahim HE, Mohamed Ibrahim MI. A survey of therapeutic drug monitoring services in Malaysia. Saudi Pharm J. 2013;21(1):19–24. doi:10.1016/j.jsps.2012.01.00223960816
   PubMed Web of Science ®Google Scholar
• Grossberg LB, Papamichael K, Feuerstein JD, Siegel CA, Ullman TA, Cheifetz AS. A survey study of gastroenterologists’ attitudes and barriers toward therapeutic drug monitoring of Anti-TNF therapy in inflammatory bowel disease. Inflamm Bowel Dis. 2017;24(1):191–197. doi:10.1093/ibd/izx02329272486
   PubMed Web of Science ®Google Scholar
• Guo W, Guo GX, Sun C, et al. Therapeutic drug monitoring of psychotropic drugs in China: a nationwide survey. Ther Drug Monit. 2013;35(6):816–822. doi:10.1097/FTD.0b013e318296a2ff24263641
   PubMed Web of Science ®Google Scholar
• Norris RL, Martin JH, Thompson E, et al. Current status of therapeutic drug monitoring in Australia and New Zealand: a need for improved assay evaluation, best practice guidelines, and professional development. Ther Drug Monit. 2010;32(5):615–623. doi:10.1097/FTD.0b013e3181ea3e8a20683393
   PubMed Web of Science ®Google Scholar
• Tabah A, De Waele J, Lipman J, et al. The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs. J Antimicrob Chemother. 2015;70(9):2671–2677. doi:10.1093/jac/dkv16526169558
   PubMed Web of Science ®Google Scholar
• Charmillon A, Novy E, Agrinier N, et al. The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for beta-lactam administration and therapeutic drug monitoring among critically ill patients in France. Clin Microbiol Infect. 2016;22(7):625–631. doi:10.1016/j.cmi.2016.04.01927145210
   PubMed Web of Science ®Google Scholar
• Cotta MO, Dulhunty JM, Roberts JA, Myburgh J, Lipman J. Should beta-lactam antibiotics be administered by continuous infusion in critically ill patients? A survey of Australia and New Zealand intensive care unit doctors and pharmacists. Int J Antimicrob Agents. 2016;47(6):436–438. doi:10.1016/j.ijantimicag.2016.02.01727179814
   PubMed Web of Science ®Google Scholar
• Fuchs A, Csajka C, Thoma Y, Buclin T, Widmer N. Benchmarking therapeutic drug monitoring software: a review of available computer tools. Clin Pharmacokinet. 2013;52(1):9–22. doi:10.1007/s40262-012-0020-y23196713
   PubMed Web of Science ®Google Scholar
• Baietto L, Corcione S, Pacini G, Perri GD, D’Avolio A, De Rosa FG. A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics? Curr Drug Metab. 2014;15(6):581–598.24909419
   PubMed Web of Science ®Google Scholar
• World Health Organization. The 20th WHO Essential Medicines List (EML) and the 6th WHO Essential Medicines List for Children (EMLc) updated in March 2017. Available from: https://www.who.int/medicines/publications/essentialmedicines/en/. Accessed 314, 2019.
   Google Scholar
• Wang P, Kricka LJ. Current and emerging trends in point-of-care technology and strategies for clinical validation and implementation. Clin Chem. 2018;64(10):1439–1452. doi:10.1373/clinchem.2018.28705229884677
   PubMed Web of Science ®Google Scholar